US Bancorp’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.25K Buy
+131
New +$1.02K ﹤0.01% 3895
2025
Q3
Sell
-271
Closed -$2.43K 4035
2025
Q2
$2.43K Buy
+271
New +$2.52K ﹤0.01% 3829
2025
Q1
Sell
-210
Closed -$1.58K 4204
2024
Q4
$1.58K Buy
+210
New +$1.59K ﹤0.01% 3897
2023
Q2
Sell
-1,126
Closed -$9.39K 3999
2023
Q1
$9.39K Buy
1,126
+1,042
+1,240% +$10K ﹤0.01% 3306
2022
Q4
$964 Sell
84
-27
-24% -$337 ﹤0.01% 3929
2022
Q3
$1K Buy
111
+27
+32% +$347 ﹤0.01% 3916
2022
Q2
$1K Sell
84
-12,016
-99% -$124K ﹤0.01% 3928
2022
Q1
$197K Buy
12,100
+500
+4% +$8.02K ﹤0.01% 1952
2021
Q4
$161K Buy
11,600
+3,006
+35% +$39.8K ﹤0.01% 2063
2021
Q3
$123K Buy
8,594
+194
+2% +$3.06K ﹤0.01% 2192
2021
Q2
$133K Sell
8,400
-3,000
-26% -$40.8K ﹤0.01% 2152
2021
Q1
$116K Buy
11,400
+9,400
+470% +$96.9K ﹤0.01% 2191
2020
Q4
$15K Buy
+2,000
New +$10.3K ﹤0.01% 3016
2020
Q3
Sell
-1,000
Closed -$5K 3713
2020
Q2
$5K Buy
+1,000
New +$3.99K ﹤0.01% 3293
2019
Q4
Sell
-4,648
Closed -$13K 3650
2019
Q3
$13K Hold
4,648
﹤0.01% 2977
2019
Q2
$18K Buy
4,648
+4,302
+1,243% +$25.9K ﹤0.01% 2914
2019
Q1
$3K Buy
+346
New +$2.96K ﹤0.01% 3332
2015
Q2
Sell
-384
Closed -$3K 3562
2015
Q1
$3K Hold
384
﹤0.01% 3373
2014
Q4
$5K Hold
384
﹤0.01% 3262
2014
Q3
$4K Buy
+384
New +$4.71K ﹤0.01% 3253

Other funds holding BCRX